PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Adicet Bio, Inc. (ACET)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0070021086
CUSIP007002108
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$119.15M
EPS (TTM)-$2.94
PEG Ratio0.82
Total Revenue (TTM)$12.89M
Gross Profit (TTM)$4.92M
EBITDA (TTM)-$118.76M
Year Range$1.10 - $4.81
Target Price$9.00
Short %10.00%
Short Ratio4.27

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Adicet Bio, Inc.

Popular comparisons: ACET vs. YRD, ACET vs. ETON

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Adicet Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%2024FebruaryMarchAprilMayJune
-98.86%
89.07%
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Adicet Bio, Inc. had a return of -28.57% year-to-date (YTD) and -70.20% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-28.57%13.87%
1 month-3.57%2.33%
6 months-15.09%15.10%
1 year-70.20%22.72%
5 years (annualized)-53.61%13.49%
10 years (annualized)N/A10.85%

Monthly Returns

The table below presents the monthly returns of ACET, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202458.20%-21.40%0.00%-36.60%-2.68%-28.57%
20232.35%-13.88%-26.90%1.39%-6.16%-55.66%9.88%-25.09%-31.50%-3.65%-10.61%60.17%-78.86%
2022-27.84%3.65%52.68%-26.19%-19.81%23.52%15.68%-16.16%0.42%15.96%10.25%-50.83%-48.89%
2021-12.46%24.47%-14.57%21.79%-15.76%-23.32%-28.09%12.84%-6.11%9.69%23.72%64.38%24.48%
2020-7.38%0.72%-25.90%48.54%41.83%-0.92%15.81%-8.43%-25.50%-9.84%15.02%13.95%34.71%
20193.02%-3.60%-20.33%18.04%-10.43%41.47%6.67%-11.58%-8.11%-17.99%-83.45%24.17%-82.71%
2018-3.91%20.22%-50.87%-6.05%8.78%-6.54%68.20%-23.13%27.98%-26.95%18.08%-34.00%-48.93%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACET is 18, indicating that it is in the bottom 18% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ACET is 1818
ACET (Adicet Bio, Inc.)
The Sharpe Ratio Rank of ACET is 1919Sharpe Ratio Rank
The Sortino Ratio Rank of ACET is 2323Sortino Ratio Rank
The Omega Ratio Rank of ACET is 2323Omega Ratio Rank
The Calmar Ratio Rank of ACET is 1010Calmar Ratio Rank
The Martin Ratio Rank of ACET is 1717Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Adicet Bio, Inc. (ACET) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ACET
Sharpe ratio
The chart of Sharpe ratio for ACET, currently valued at -0.60, compared to the broader market-2.00-1.000.001.002.003.00-0.60
Sortino ratio
The chart of Sortino ratio for ACET, currently valued at -0.57, compared to the broader market-4.00-2.000.002.004.006.00-0.57
Omega ratio
The chart of Omega ratio for ACET, currently valued at 0.93, compared to the broader market0.501.001.502.000.93
Calmar ratio
The chart of Calmar ratio for ACET, currently valued at -0.71, compared to the broader market0.002.004.006.00-0.71
Martin ratio
The chart of Martin ratio for ACET, currently valued at -1.19, compared to the broader market-10.000.0010.0020.00-1.19
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.14, compared to the broader market-2.00-1.000.001.002.003.002.14
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.04, compared to the broader market-4.00-2.000.002.004.006.003.04
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.71, compared to the broader market0.002.004.006.001.71
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.02, compared to the broader market-10.000.0010.0020.008.02

Sharpe Ratio

The current Adicet Bio, Inc. Sharpe ratio is -0.60. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Adicet Bio, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.002024FebruaryMarchAprilMayJune
-0.60
2.14
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Adicet Bio, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2024FebruaryMarchAprilMayJune
-99.08%
-0.04%
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adicet Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adicet Bio, Inc. was 99.24%, occurring on Nov 28, 2023. The portfolio has not yet recovered.

The current Adicet Bio, Inc. drawdown is 99.08%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.24%Feb 26, 20181450Nov 28, 2023
-6.75%Jan 29, 20182Jan 30, 20183Feb 2, 20185
-5.63%Feb 5, 20182Feb 6, 20184Feb 12, 20186
-0.88%Feb 14, 20181Feb 14, 20182Feb 16, 20183
-0.2%Feb 22, 20181Feb 22, 20181Feb 23, 20182

Volatility

Volatility Chart

The current Adicet Bio, Inc. volatility is 22.83%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%2024FebruaryMarchAprilMayJune
22.83%
2.26%
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Adicet Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items